FDA Updates for the Week of Aug. 28, 2023
FDA Updates for the Week of Aug. 28, 2023 unknown
FDA Approves Reblozyl as First-Line Treatment in MDS-Related Anemia
The
Healthcare Dealmakers—Oregon's $6.6B hospital merger and more
Healthcare Dealmakers—Oregon's $6.6B hospital merger and more unknown Healthcare Dealmakers—Oregon's $6.6B hospital
Sept. 1 - Roz Brewer steps down suddenly as Walgreens CEO
Sept. 1 - Roz Brewer steps down suddenly as Walgreens CEO PharmaVoice
Ketamine and psychedelics delivery tech in the spotlight
AION Receives FDA Clearance for Its iTempShield Skin-Wearable Device and Software Platform for Professional and Retail Environments
Technology Designed for Multiple Applications, with Initial Focus on Early Infection Detection and Treatment
August 30, 2023 07:05 AM
Reflection paper on the use of artificial intelligence in the lifecycle of medicines
News 19/07/2023
EMA has published a draft reflection paper outlining the current thinking on the use of artificial
The Telemedicine Program Design Canvas: a visual tool for planning telemedicine interventions
Oxford Open Digital Health, Volume 1, 2023, oqac002, https://doi.org/10.1093/oodh/oqac002Published: 20 December 2022
Telemedicine has
Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system
Background
Exercise can rapidly drop glucose in people with type 1 diabetes. Ubiquitous wearable fitness sensors are not integrated into
HOW AI-POWERED DRUG DEVELOPMENT IS RESHAPING PHARMACEUTICAL RESEARCH
This is a post from the Visium Blog by Matteo Togninalli, Chief Operating Officer
Aug 28, 2023 • 12 min. read
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
The potential for gene therapies to treat – or even effectively cure – debilitating medical conditions continues to expand. Our latest quarterly
Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM): A Deep Dive into Proposed Medicare Changes
Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM): A Deep Dive into Proposed Medicare Changes Foley & Lardner LLP